2-(2-(Difluoromethyl)-4,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 2.5g

N-(2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95+%, 50mg

4-[(2-Bromophenyl)methyl]oxan-4-yl-methanamine hydrochloride, 1g

TRIS[(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)METHYL]AMINE, 96%, 250mg

[(1-isobutyl-1H-imidazol-5-yl)methyl]amine dihydrochloride, 95.0%, 10g

Hydrobromic acid, 33% in Acetic Acid, 25g

(E)-1-(4-(4-aminophenyl)piperazin-1-yl)-3-phenylprop-2-en-1-one, 95%, 250mg

Dibenzo[b,f][1,4]oxazepin-11(10H)-one, 95.0%, 1g

9-Amino-1,2,3,4-tetrahydroacridine hydrochloride hydrate, 97.0%, 250mg

5-Iodothiophene-2-carboxylic acid, 95.0%, 1g

Dansyl-L-leucine, 98%, 250mg

2-(2-Chloro-6-fluorophenyl)acetohydrazide, 95.0%, 1g

1-(2-BROMOETHOXY)-3-CHLOROBENZENE, 95.0%, 1g